Mirum Pharmaceuticals (MIRM) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 82.0%
EBITDA Margin: -489.5%
Op. Margin: -493.8%
Net Margin: -494.2%

Op. margin of -493.8% is down 480.2% YoY — costs are rising relative to revenue. Net margin at -494.2% and gross margin of 82.0% — earnings take a bigger bite when COGS stays lean..

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit